SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/7A82C165E35831B3DEF7FCA8F952208F5B8BA0C92704380F5631A0604707B141F3A82775F8AF0C3A8BB625ACFCD6B7C9>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/7A82C165E35831B3DEF7FCA8F952208F5B8BA0C92704380F5631A0604707B141F3A82775F8AF0C3A8BB625ACFCD6B7C9
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/7A82C165E35831B3DEF7FCA8F952208F5B8BA0C92704380F5631A0604707B141F3A82775F8AF0C3A8BB625ACFCD6B7C9
http://www.w3.org/2000/01/rdf-schema#comment
"Results characterize a novel immunosuppressant which shows potential anti-tumor effects on gastric cancer by PTEN activation through p53-independent mechanism especially in combination with Cisplatin."
xsd:string
http://purl.uniprot.org/uniprot/#_8F3D26A616726AF5FCB7F74F4708D660B5EB57BD3BD6325A2107A838723A650CED73022D59907864EF3E260EEB5D7C0B
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/7A82C165E35831B3DEF7FCA8F952208F5B8BA0C92704380F5631A0604707B141F3A82775F8AF0C3A8BB625ACFCD6B7C9
http://purl.uniprot.org/uniprot/A0A346XM43
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/7A82C165E35831B3DEF7FCA8F952208F5B8BA0C92704380F5631A0604707B141F3A82775F8AF0C3A8BB625ACFCD6B7C9
http://purl.uniprot.org/uniprot/#_A0A346XM43-mappedCitation-20506484
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/7A82C165E35831B3DEF7FCA8F952208F5B8BA0C92704380F5631A0604707B141F3A82775F8AF0C3A8BB625ACFCD6B7C9